RxDoctor Payments Data

Laurie Foster

Nurse Practitioner · Jackson, MSNPI 1962854323

Payments from drug & device makers

$1,593in general payments, 2019–2025

Across 106 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$586
  • Novartis$267
  • Amgen$174
  • E.r. Squibb & Sons, L.L.C.$144
  • Johnson & Johnson$97
  • AstraZeneca$81
  • plus $245 from 11 others

What the payments were for

  • Food & beverage$1,593100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,593 in reported general payments places this provider in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$39,630
Medicare patients
337
Services billed
768

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept36$254,876
Humira(Cf) PenAdalimumab34$235,618
Enbrel MiniEtanercept18$120,773
Orencia ClickjectAbatacept18$107,414
OrenciaAbatacept/Maltose20$85,990
Xeljanz XrTofacitinib Citrate14$74,761
RinvoqUpadacitinib11$66,945
BenlystaBelimumab12$47,244
Hydroxychloroquine Sulfate116$6,465
MethotrexateMethotrexate Sodium82$2,824
Leflunomide37$1,912
Gabapentin75$1,226
Duloxetine Hcl38$757
Pregabalin35$719
Prednisone76$660

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
E.r. Squibb & Sons, L.L.C.Orencia$144$85,99020 claims
AbbVieRinvoq$586$66,94511 claims
Fresenius Kabi USA, LLCSodium Chloride$18$11533 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →